Sihuan Pharmaceutical Holdings Group Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHPHF research report →
Companywww.sihuanpharm.com
Sihuan Pharmaceutical Holdings Group Ltd. , an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas.
- CEO
- Weicheng Guo
- IPO
- 2012
- Employees
- 2,667
- HQ
- Wan Chai, HK
Price Chart
Valuation
- Market Cap
- $1.69B
- P/E
- 44.93
- P/S
- 3.09
- P/B
- 1.38
- EV/EBITDA
- 8.26
- Div Yield
- 1.06%
Profitability
- Gross Margin
- 68.83%
- Op Margin
- 23.19%
- Net Margin
- 6.86%
- ROE
- 3.51%
- ROIC
- 3.31%
Growth & Income
- Revenue
- $2.55B · 34.16%
- Net Income
- $175.06M · 180.80%
- EPS
- $0.02 · 180.77%
- Op Income
- $382.35M
- FCF YoY
- -479.16%
Performance & Tape
- 52W High
- $0.21
- 52W Low
- $0.05
- 50D MA
- $0.18
- 200D MA
- $0.12
- Beta
- 0.97
- Avg Volume
- 1.66K
Get TickerSpark's AI analysis on SHPHF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SHPHF Coverage
We haven't published any research on SHPHF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SHPHF Report →